Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 67

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 2
Chunk 67
---
 of our stockholders could be significantly diluted, and the
newly issued equity securities may have rights, preferences, or privileges senior to those of the holders of our common stock. If we
raise funds through the issuance of debt securities, those securities may have rights, preferences, and privileges senior to those of
our common stock. If we seek strategic alliances, licenses, or other alternative arrangements, such as arrangements with collaborative
partners or others, we may need to relinquish rights to certain of our existing or future technologies, drug candidates, or products
we would otherwise seek to develop or commercialize on our own, or to license the rights to our technologies, drug candidates, or products
on terms that are not favorable to us. The overall status of the economic climate could also result in the terms of any equity offering,
debt financing, or alliance, license, or other arrangement being even less favorable to us and our stockholders than if the overall economic
climate were stronger. We also will continue to look for government sponsored research collaborations and grants to help offset future
anticipated losses from operations and, to a lesser extent, interest income.

If
adequate funds are not available through either the capital markets, strategic alliances, or collaborators, we may be required to delay
or, reduce the scope of, or terminate our research, development, clinical programs, manufacturing, or commercialization efforts, or effect
additional changes to our facilities or personnel, or obtain funds through other arrangements that may require us to relinquish some
of our assets or rights to certain of our existing or future technologies, drug candidates, or products on terms not favorable to us.

Such
conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes
raising funds from the issuance and sale of its common stock via its ATM program and other funding transactions. However, as mentioned
above, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company
or will provide the Company with sufficient funds to meet its objectives. The Company’s financial statements do not include any
adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities
that may be required should the Company be unable to continue as a going concern.

Off-Balance
Sheet Arrangements and Contractual Obligations

None.

Item
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We
are